The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma
KCMJ Peeters, CAM Marijnen, ID Nagtegaal… - Annals of …, 2007 - journals.lww.com
Objective: To investigate the efficacy of preoperative short-term radiotherapy in patients with
mobile rectal cancer undergoing total mesorectal excision (TME) surgery. Summary …
mobile rectal cancer undergoing total mesorectal excision (TME) surgery. Summary …
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international …
…, SM Murad-Regadas, ST O'Dwyer, KCMJ Peeters… - The Lancet, 2018 - thelancet.com
Background The strategy of watch and wait (W&W) in patients with rectal cancer who
achieve a complete clinical response (cCR) after neoadjuvant therapy is new and offers an …
achieve a complete clinical response (cCR) after neoadjuvant therapy is new and offers an …
[HTML][HTML] Preoperative risk factors for major postoperative complications after complex gastrointestinal cancer surgery: A systematic review
RT van Kooten, RR Bahadoer, KCMJ Peeters… - European Journal of …, 2021 - Elsevier
Patients undergoing complex gastrointestinal surgery are at high risk of major postoperative
complications (eg, anastomotic leakage, sepsis), classified as Clavien-Dindo (CD) ≥ IIIa. …
complications (eg, anastomotic leakage, sepsis), classified as Clavien-Dindo (CD) ≥ IIIa. …
A multivariate analysis of limiting factors for stoma reversal in patients with rectal cancer entered into the total mesorectal excision (TME) trial: a retrospective study
M den Dulk, M Smit, KCMJ Peeters… - The lancet …, 2007 - thelancet.com
Background In many patients with rectal cancer, defunctioning stomas are created to limit
the consequences of anastomotic leakage. Although intended to be temporary, a substantial …
the consequences of anastomotic leakage. Although intended to be temporary, a substantial …
Allogeneic bone marrow–derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn's disease
I Molendijk, BA Bonsing, H Roelofs, KCMJ Peeters… - Gastroenterology, 2015 - Elsevier
Background & Aims Patients with perianal fistulizing Crohn’s disease have a poor prognosis
because these lesions do not heal well. We evaluated the effects of local administration of …
because these lesions do not heal well. We evaluated the effects of local administration of …
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
…, L van den Nieuwenhof, KCMJ Peeters… - The lancet …, 2019 - thelancet.com
Background Nearly a quarter of patients with locally advanced (T4 stage) or perforated colon
cancer are at risk of developing peritoneal metastases, often without curative treatment …
cancer are at risk of developing peritoneal metastases, often without curative treatment …
Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the …
…, A Pairola, M Paraoan, O Pares, KCMJ Peeters… - The Lancet …, 2021 - thelancet.com
Background Watch and wait is a novel management strategy in patients with rectal cancer
who have a clinical complete response after neoadjuvant chemoradiotherapy. Surveillance of …
who have a clinical complete response after neoadjuvant chemoradiotherapy. Surveillance of …
Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation …
…, DE Hilling, FA Holman, KCMJ Peeters… - The Lancet …, 2018 - thelancet.com
Background Tumour-targeted fluorescence imaging has the potential to advance current
practice of oncological surgery by selectively highlighting malignant tissue during surgery. …
practice of oncological surgery by selectively highlighting malignant tissue during surgery. …
High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity
…, AF Sarasqueta, A Mahfouz, KCMJ Peeters… - Gut, 2020 - gut.bmj.com
Objective A comprehensive understanding of anticancer immune responses is paramount for
the optimal application and development of cancer immunotherapies. We unravelled local …
the optimal application and development of cancer immunotherapies. We unravelled local …
Long-term evaluation of allogeneic bone marrow-derived mesenchymal stromal cell therapy for Crohn's disease perianal fistulas
…, WE Fibbe, DW Hommes, KCMJ Peeters… - Journal of Crohn's …, 2020 - academic.oup.com
Background and Aims The long-term safety and efficacy of allogeneic bone marrow-derived
mesenchymal stromal cell [bmMSC] therapy in perianal Crohn’s disease [CD] fistulas is …
mesenchymal stromal cell [bmMSC] therapy in perianal Crohn’s disease [CD] fistulas is …